In the BioHarmony Drug Report Database

"Preview" Icon

Dihydroergotamine

D.h.e, Migranal (dihydroergotamine) is a small molecule pharmaceutical. Dihydroergotamine was first approved as D.h.e on 1982-01-01. It is used to treat cluster headache, migraine disorders, orthostatic hypotension, postpartum hemorrhage, and xerostomia in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 1B, and 5-hydroxytryptamine receptor 6.

 

Trade Name

 

D.h.e., Migranal
 

Common Name

 

dihydroergotamine
 

ChEMBL ID

 

CHEMBL1732
 

Indication

 

cluster headache, migraine disorders, orthostatic hypotension, postpartum hemorrhage, xerostomia
 

Drug Class

 

Ergot alkaloid derivatives

Image (chem structure or protein)

Dihydroergotamine structure rendering